Immune-based therapies for cytomegalovirus infection.

Immune-based therapies for cytomegalovirus infection.

Item
http://www.wikidata.org/entity/Q37773240
Cytomegalovirus-induced immunopathology and its clinical consequencesSynthetic DNA approach to cytomegalovirus vaccine/immune therapyVaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.Cytomegalovirus pneumonia in hematopoietic stem cell recipients.Strategies for managing cytomegalovirus in transplant recipients.Management of viral infections in solid organ transplant recipients.Immune response to CMV in solid organ transplant recipients: current concepts and future directions.Cytomegalovirus infection in liver transplant recipients: updates on clinical managementAugmented adenovirus transduction of murine T lymphocytes utilizing a bi-specific protein targeting murine interleukin 2 receptor.Human embryonic lung fibroblasts treated with artesunate exhibit reduced rates of proliferation and human cytomegalovirus infection in vitro
P2860

Immune-based therapies for cytomegalovirus infection.

Item
http://www.wikidata.org/entity/Q37773240
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune-based therapies for cytomegalovirus infection.
@en
Immune-based therapies for cytomegalovirus infection.
@nl
type
label
Immune-based therapies for cytomegalovirus infection.
@en
Immune-based therapies for cytomegalovirus infection.
@nl
prefLabel
Immune-based therapies for cytomegalovirus infection.
@en
Immune-based therapies for cytomegalovirus infection.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Immune-based therapies for cytomegalovirus infection.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921